Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

186 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-02

Study Completion Date

2018-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Micronutrient Supplementation in PCO-syndrome

NCT03306745

Polycystic Ovary Syndrome Infertility, Female Micronutrient Deficiency

COMPLETED NA

Role of Myo-inositol and D-chiro Inositol on the Ovaric and Metabolic Functions

NCT01626443

PCOS

COMPLETED PHASE4

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

NCT02651636

Polycystic Ovary Syndrome Menstrual Pattern Hyperandrogenism +1 more

COMPLETED NA

Treatment of Women With PCOS of Phenotype D

NCT06639698

PCOS (Polycystic Ovary Syndrome)

COMPLETED NA

A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance

NCT06158932

Polycystic Ovary Syndrome Hormone Imbalance

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome Menstrual Problem Hirsutism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Myo-inositol+L-tyrosine

One sachet per day containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid for improving PCOS symptoms.

Group Type EXPERIMENTAL

Myo-inositol+L-tyrosine

Intervention Type DIETARY_SUPPLEMENT

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myo-inositol+L-tyrosine

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment.

Intervention Type DIETARY_SUPPLEMENT